You are here: Industry Insights > siRNA

News List

Novartis' Global Innovative siRNA Long-Acting Lipid-lowering Therapy Submitted Clinical Application in China PharmaSources/Xiaoyaowan
July 01, 2020
On June 28, the CDE official website showed that Novartis' siRNA long-acting lipid-lowering drug Inclisiran submitted a clinical application in China and has been accepted and accepted.
Siranomics begins phase-I trial of siRNA drug candidate STP707 to treat tumours ExpressPharma
February 11, 2022
The phase-I clinical trial, a multi-centre, open-label, dose-escalation and dose-expansion study, will evaluate the safety, tolerability and anti-tumour activity of STP707.
Silence Therapeutics Gets Milestone Payment from Mallinckrodt Collaboration americanpharmaceuticalreview
April 30, 2021
Silence Therapeutics announced that it has achieved another research milestone as part of its ongoing RNAi collaboration with Mallinckrodt plc for complement-mediated diseases, triggering a further $2.0 million payment to Silence.
AstraZeneca, Silence Therapeutics Announce siRNA Collaboration americanpharmaceuticalreview
March 31, 2020
AstraZeneca will collaborate with Silence Therapeutics to discover, develop and commercialize small interfering RNA (siRNA) therapeutics for the treatment of Cardiovascular, Renal, Metabolic and Respiratory diseases.
AstraZeneca and Silence Therapeutics sign drug development deal pharmaceutical-technology
March 27, 2020
AstraZeneca has partnered with Silence Therapeutics for the discovery, development and commercialisation of small interfering RNA (siRNA) drugs for cardiovascular, renal, metabolic and respiratory diseases.
AZ to develop siRNA with Silence Theraputics pharmatimes
March 26, 2020
AstraZeneca has revealed plans to collaborate with Silence Therapeutics to discover, develop and commercialise small interfering RNA (siRNA) therapeutics for the treatment of cardiovascular, renal, metabolic and respiratory diseases.
Unique hydrogel strategy aids the delivery of drugs europeanpharmaceuticalreview
September 02, 2019
Scientists have developed a hydrogel-based carrier that can deliver siRNAs directly to where they are needed.